BERLIN, Oct 21 (AFP) - German researchers deplored Tuesday the lack of funding in Germany dedicated to efforts to find a vaccine for AIDS and called on the government to rethink its priorities.
"According to our calculations, the budget for research into an AIDS vaccine is about seven million euros (8.2 million dollars)," said Bernhard Fleckenstein, head of research at Erlangen-Nuremberg University.
"That is around 300 times less than in the United States," he said.
The director of the Robert Koch Institute, a research facility specialising in contagious diseases, complained the German government had not set clear goals in the fight against AIDS.
"All the research sectors are treated in the same way," said Reinhard Kurth, and he called for more funds to fight what he described as "the biggest medical catastrophe of modern times."
The researchers are among 25 scientists holding a two-day conference at the Institute in Berlin on developments in Germany's fight against AIDS.
031021
AF031067
©AFP 2003. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission. obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. - http://www.afp.com/
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
©1990, 2003 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.